News

First call for training modules

EVI and Processing personal data on the basis of the EU/EEA General Data Protection Regulation

Phase II clinical trials in Sudan of a therapeutic vaccine to prevent post kala azar dermal leishmaniasis to be supported by European & Developing Countries Clinical Trials Partnership

EVI 20th Anniversary Symposium in Heidelberg, Germany, 20-21 November 2018

European Vaccine Initiative reports positive clinical trial results for two malaria vaccines and calls for further increase in investments into malaria research and development

TRANSVAC is an infrastructure project that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges.  This short movie explains you what the whole initiative is about.

 

 

Findings from a workshop organised within the VAC2VAC project (Vaccine batch to vaccine batch comparison by consistency testing) on the improved design of multi-centre validation studies and the use the data generated for product-specific validation purposes have now been published (Halder et al, 2018). The recommendations also address aspects of validation within the consistency approach context

European Vaccine Initiative (EVI) begins its third decade developing vaccines for diseases against poverty. Fundraising management and reporting are crucial aspects for EVI’s strategic planning and stakeholders’ engagement.

Thanks to SAP, EVI’s financial reporting is now streamlined and more efficient. For more information, please click here